
TORL Biotherapeutics LLC
TORL Biotherapeutics LLC is a biopharmaceutical company focused on the discovery, development, and commercialization of novel antibody-based therapies to improve and extend the lives of cancer patients.
Funding history
About TORL Biotherapeutics LLC
How much funding has TORL Biotherapeutics LLC raised?
TORL Biotherapeutics LLC has raised $158.3M in total funding. The most recent round was Series C.
Where is TORL Biotherapeutics LLC headquartered?
TORL Biotherapeutics LLC is headquartered in Culver City, CA.
What does TORL Biotherapeutics LLC do?
TORL Biotherapeutics LLC is a biopharmaceutical company focused on the discovery, development, and commercialization of novel antibody-based therapies to improve and extend the lives of cancer patients.
What makes TORL Biotherapeutics LLC notable?
Founded in 2019 with co-founder Dave Licata, and has raised over $450 million total, with investors including Goldman Sachs Asset Management and Blue Owl Capital.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.